Cargando…
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
OBJECTIVE: The treatment of Acute Myeloid Leukemia (AML) leads to several functional limitations. Especially cardiac burden following cardiotoxic chemotherapy, which limits exercise and competitive sport in the long-term survivors. SUBJECT AND METHODS: We report on a young female amateur triathlete...
Autores principales: | von Korn, Pia, Vogt, Manfred, Oberhoffer, Renate, Ewert, Peter, Müller, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837142/ https://www.ncbi.nlm.nih.gov/pubmed/33530145 http://dx.doi.org/10.1186/s40959-016-0016-0 |
Ejemplares similares
-
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Nerve Entrapment Syndromes in Competitive Triathletes
por: Palafox, Damián
Publicado: (2020) -
The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014) -
Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)